carbostyril has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Alonso-Alonso, R; Burrows, F; Esteve-Codina, A; Fuste, B; García-Diaz, N; Gualberto, A; Gut, M; Martínez, N; Merino, D; Mondéjar, R; Pérez, C; Piris, MÁ; Rodríguez, M; Scholz, C; Vaqué, JP | 1 |
| Agarwal, A; Chang, BH; Christensen, DJ; Cleary, MM; Jeng, S; Look, AT; Mahmood, S; McWeeney, S; Odero, MD; Pippa, R; Puri, A; Richard, NP; Sears, R; Tibbitts, D; Tyner, JW; Vitek, MP | 1 |
| Astolfi, A; Biagi, C; Chiarini, F; Franzoni, M; Masetti, R; Melchionda, F; Pession, A; Serravalle, S | 1 |
3 other study(ies) available for carbostyril and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
Identification of tipifarnib sensitivity biomarkers in T-cell acute lymphoblastic leukemia and T-cell lymphoma.
Topics: Apoptosis; Biomarkers, Tumor; Cell Cycle; Cell Line, Tumor; Cell Survival; Down-Regulation; Drug Resistance, Neoplasm; Gene Expression Regulation, Leukemic; Humans; Inhibitory Concentration 50; Lymphoma, T-Cell; Mutation; Phenotype; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Quinolones; Signal Transduction; T-Lymphocytes | 2020 |
Combined targeting of SET and tyrosine kinases provides an effective therapeutic approach in human T-cell acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Cell Line, Tumor; Cell Survival; Child; DNA-Binding Proteins; Enzyme Inhibitors; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histone Chaperones; Humans; Jurkat Cells; Male; Peptides; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Protein Phosphatase 2; Protein-Tyrosine Kinases; Quinolones; Transcription Factors; Young Adult | 2016 |
Pediatric early T-cell precursor leukemia with NF1 deletion and high-sensitivity in vitro to tipifarnib.
Topics: Antineoplastic Agents; Child; Female; Humans; In Vitro Techniques; Neurofibromin 1; Polymorphism, Single Nucleotide; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Quinolones; Sequence Deletion | 2010 |